INNOGENE Changes Management via 3.36 Billion Won Third-Party Allotment, Issuing 2.4 Million New Shares Diluting Existing Shareholders
INNOGENE has entered into a management change contract with its largest shareholder Lee Kwang-hoon, Metamorphosis Co., Ltd., and Jeong Ki-cheol. Under the contract, the company will issue 2.4 million new shares at 1,400 won per share to raise a total of 3.36 billion won.
The new share issuance will increase total outstanding shares by approximately 20%, significantly diluting existing shareholders' equity value. Although the issue price is about 9.8% above the current share price, the large volume poses a burden.
The acquirer Metamorphosis is a small company with assets of about 1.9 billion won, raising concerns about financial stability and execution capability. Moreover, there is no lock-up period, increasing the risk of short-term selling.
[AI Summary]This management change via new share issuance results in approximately 20% dilution, negatively impacting existing shareholders. The acquirer's weak financials and unclear business plan elevate investment risk.